Ampersand Capital Acquires Willow Laboratories

Willow Laboratories, based in Lynn, Mass., has been acquired by Ampersand Capital Partners. Willow is a clinical and forensic toxicology laboratory that provides urine, hair, and saliva testing services to a wide range of healthcare providers, including treatment centers. Ampersand is a Boston-based, middle market private equity firm. Terms of the deal were not disclosed.

PEHUB Community

Join the 12493 members of peHUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Psst! Got any hot tips?

  • This field is for validation purposes and should be left unchanged.

Look Who’s Tweeting

Reuters VC and PE feed

RSS Feed Widget

Groups